Results 71 to 80 of about 24,035 (181)
Brazilian Journal of Infectious DiseasesIntroduction: Meningitis is a communicable infectious disease with a significant disease burden and possible unfavorable outcomes. In this context, the World Health Organization (WHO) and the Pan American Health Organization (PAHO) developed the roadmap “
Nathália Amaro Schmidt +1 more
doaj +1 more source
A rare case of peripheral facial paralysis associated with meningococcal meningitis - case report [PDF]
Romanian Journal of PediatricsIntroduction. Meningococcal meningitis is a severe form of bacterial meningitis caused by the bacterium Neisseria meningitidis (N. meningitidis). It is a medical emergency and requires prompt treatment to prevent severe complications or death. Peripheral
Nicoleta-Ana Tomsa +3 more
doaj +1 more source
Impact of serogroup A meningococcal conjugate vaccine for Africa
Human Vaccines & Immunotherapeutics, 2018 The introduction of a serogroup A meningococcal conjugate vaccine in the African meningitis belt has been a remarkable success. Meningitis due to the serogroup A meningococcus, previously responsible for most epidemics, has fallen by 99% in vaccinated ...
James M. Stuart
doaj +1 more source
Invasive Meningococcal Disease in a Patient With Complement 7 Deficiency
Journal of General and Family Medicine, Volume 26, Issue 6, Page 646-649, November 2025.ABSTRACT Neisseria meningitidis can cause invasive meningococcal disease (IMD). Individuals with primary complement deficiencies are at a higher risk of developing IMD. However, cases of IMD associated with complement deficiency have rarely been reported in Japan.
Hiroaki Nishioka +2 more
wiley +1 more source
Iowa Health Focus, September 2004 [PDF]
, 2004 Monthly newsletter for the Iowa Department of Public ...
core
Clinical features and outcome of sporadic serogroup W135 disease Taiwan [PDF]
, 2006 Background Few published reports have evaluated the clinical features and outcome of serogroup W135 meningococcal disease. In Taiwan, W135 is the second most prevalent meningococcal disease serogroup.
Jiun-Ling Wang +6 more
core +2 more sources
Vaccination in Multiple Myeloma: Challenges and Strategies
European Journal of Haematology, Volume 115, Issue 4, Page 334-343, October 2025.ABSTRACT Background Multiple myeloma (MM) is a hematological malignancy characterized by profound immunosuppression resulting from both disease‐related mechanisms and treatment‐induced immune dysfunction. This compromised immune status markedly increases susceptibility to infections, a leading cause of morbidity and mortality in MM patients.
Enrica Antonia Martino +10 more
wiley +1 more source
EPI Update, June 22, 2007 [PDF]
, 2007 Weekly newsletter for Center For Acute Disease Epidemiology of Iowa Department of Public ...
core
Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017.
PLoS ONE, 2018 BackgroundNigeria reports high rates of mortality linked with recurring meningococcal meningitis outbreaks within the African meningitis belt. Few studies have thoroughly described the response to these outbreaks to provide strong and actionable public ...
Assad Hassan +12 more
doaj +1 more source
Vaccines against Meningococcal Diseases
Microorganisms, 2020 Neisseria meningitidis is the main cause of meningitis and sepsis, potentially life-threatening conditions. Thanks to advancements in vaccine development, vaccines are now available for five out of six meningococcal disease-causing serogroups (A, B, C, W,
Mariagrazia Pizza +2 more
doaj +1 more source